Trientine Hydrochloride
NDC 16571-810, Trientine Hydrochloride, capsule, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-810
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212238
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIENTINE HYDROCHLORIDE250 mg/1
Pharmacologic classes
Copper Chelating Activity [MoA]; Copper Chelator [EPC]; Metal Chelating Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-810-01 | 16571081001 | 100 CAPSULE in 1 BOTTLE (16571-810-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f33c1322-f7c0-4684-afc8-8caa3f4023dcNADAC price for package 16571081001
GET /v1/drugs/nadac/16571081001
Use it
Look up 16571-810 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-810 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.